Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy

被引：43

作者：

Martínez, E

García-Viejo, MA

Marcos, MA

Pérez-Cuevas, JB

Blanco, JL

Mallolas, J

Miró, JM

Gatell, JM

机构：

[1] Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed August Pi I Sunyer, Infect Dis Unit, Barcelona, Spain

[2] Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed August Pi I Sunyer, Microbiol Unit, Barcelona, Spain

来源：

AIDS | 2000年 / 14卷 / 16期

关键词：

D O I：

10.1097/00002030-200011100-00029

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：2615 / 2617

页数：3

共 6 条

[1]

ABERG JA, 2000, P 7 C RETR OPP INF S

[2]

[Anonymous], 1999, MMWR Recomm Rep, V48, P1

[3] Serum cryptococcal antigen in patients with AIDS [J].

Feldmesser, M ;

Harris, C ;

Reichberg, S ;

Khan, S ;

Casadevall, A .

CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) :827-830

[4] Drug therapy: Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. [J].

Kovacs, JA ;

Masur, H .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (19) :1416-1429

[5] MEASUREMENT OF CRYPTOCOCCAL ANTIGEN IN SERUM AND CEREBROSPINAL-FLUID - VALUE IN THE MANAGEMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS [J].

POWDERLY, WG ;

CLOUD, GA ;

DISMUKES, WE ;

SAAG, MS .

CLINICAL INFECTIOUS DISEASES, 1994, 18 (05) :789-792

[6] Practice guidelines for the management of cryptococcal disease [J].

Saag, MS ;

Graybill, RJ ;

Larsen, RA ;

Pappas, PG ;

Perfect, JR ;

Powderly, WG ;

Sobel, JD ;

Dismukes, WE .

CLINICAL INFECTIOUS DISEASES, 2000, 30 (04) :710-718

← 1 →